$96.58
0.85% day before yesterday
Nasdaq, Sep 06, 10:00 pm CET
ISIN
US5898891040
Symbol
MMSI

Merit Medical Systems, Inc. Stock price

$96.58
+7.00 7.81% 1M
+21.73 29.03% 6M
+20.62 27.15% YTD
+31.81 49.11% 1Y
+23.59 32.32% 3Y
+65.96 215.41% 5Y
+84.23 682.02% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.83 0.85%
ISIN
US5898891040
Symbol
MMSI
Sector

Key metrics

Market capitalization $5.62b
Enterprise Value $5.85b
P/E (TTM) P/E ratio 48.14
EV/FCF (TTM) EV/FCF 32.52
EV/Sales (TTM) EV/Sales 4.51
P/S ratio (TTM) P/S ratio 4.33
P/B ratio (TTM) P/B ratio 4.38
Revenue growth (TTM) Revenue growth 8.88%
Revenue (TTM) Revenue $1.30b
EBIT (operating result TTM) EBIT $154.03m
Free Cash Flow (TTM) Free Cash Flow $180.00m
Cash position $638.71m
EPS (TTM) EPS $2.01
P/E forward 45.38
P/S forward 4.19
EV/Sales forward 4.37
Short interest 6.78%
Show more

Is Merit Medical Systems, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Merit Medical Systems, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Merit Medical Systems, Inc. forecast:

9x Buy
75%
3x Hold
25%

Analyst Opinions

12 Analysts have issued a Merit Medical Systems, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Merit Medical Systems, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
1,298 1,298
9% 9%
100%
- Direct Costs 727 727
6% 6%
56%
572 572
12% 12%
44%
- Selling and Administrative Expenses 228 228
1% 1%
18%
- Research and Development Expense 83 83
2% 2%
6%
261 261
31% 31%
20%
- Depreciation and Amortization 107 107
13% 13%
8%
EBIT (Operating Income) EBIT 154 154
48% 48%
12%
Net Profit 117 117
31% 31%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Merit Medical Systems, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merit Medical Systems, Inc. Stock News

Neutral
Seeking Alpha
about one month ago
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q2 2024 Results Conference Call August 1, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Mike Matson - Needham Larry Bieg...
Neutral
GlobeNewsWire
about one month ago
Second Quarter 2024 Highlights† Reported revenue of $338.0 million, up 5.6% Constant currency revenue* up 6.6% Constant currency revenue, organic,* up 5.0% GAAP operating margin of 13.6%, compared to 9.0% in prior year period Non-GAAP operating margin* of 20.1%, compared to 19.1% in prior year period GAAP EPS $0.61, up 75.7% Non-GAAP EPS* $0.92, up 16.8% † Comparisons noted in the bullet points...
Neutral
GlobeNewsWire
about one month ago
SOUTH JORDAN, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced plans to release findings from its WAVE study. A pivotal, international, multicenter trial, the WAVE study examines the safety and efficacy of Merit's WRAPSODY Cell-Impermeable Endoprosthesis for treatment of stenosis in the venous outflow c...
More Merit Medical Systems, Inc. News

Company Profile

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Head office United States
CEO Fred Lampropoulos
Employees 6,950
Founded 1987
Website www.merit.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today